Topical, Mucosal Vaccines and Therapies
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
124
NCT04148118
A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults
Phase: Phase 1
Role: Lead Sponsor
Start: Jan 8, 2020
Completion: Sep 2, 2021
NCT05397119
A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Pandemic Flu Vaccine in Healthy Adults
Start: Jul 7, 2022
Completion: Oct 12, 2023
Loading map...